澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein.

J. Endocrinol. Invest.. 2013; 
WuJ,LinH,LiuD,LiuJ,WangN,MeiX,SunJ,YangG,Zh
Products/Services Used Details Operation
Gene Synthesis … The following oligonucleotide primers were designed and synthe- sised by Genscript Corporation (Piscataway, NJ, USA): Trx for- ward 5'-GGTAGTGGACTTCTCTGCCAC-3', reverse 5'- AGAACTGGAAGGTCGGCATGC-3', cDNA size 170 bp; Txnip forward 5 … Get A Quote

摘要

Thioredoxin-interacting protein (Txnip), an inhibitor of thioredoxin (Trx), increases in diabetic nephropathy and promotes oxidative stress. The angiotensin II (Ang II) receptor blocker telmisartan may protect renal function in diabetic models and patients via multiple effects including antioxidation. However, its mechanism has not been fully elucidated, and its relationship to Txnip remains unclear.

关键词